Exosome nanoparticles produced by cells may offer diagnostic and therapeutic potential that align to cellular therapies. In this video, Prof. Steve Conlan, Director of Innovation and head of the Reproductive Biology and Gynecological Oncology research group at Swansea University Medical School, discusses how the production and purification of exosomes may form a biopharmaceutical option for cancer patients in the future.